A1D65

Napabucasin

Created:2024-03-28
Last modified:  2025-11-13
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count26
Chiral Atom Count0
Bond Count28
Aromatic Bond Count11
2D diagram of A1D65
Chemical Component Summary
NameNapabucasin
Systematic Name (OpenEye OEToolkits)2-ethanoylbenzo[f][1]benzofuran-4,9-dione
FormulaC14 H8 O4
Molecular Weight240.211
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESCACTVS3.385CC(=O)c1oc2C(=O)c3ccccc3C(=O)c2c1
SMILESOpenEye OEToolkits2.0.7CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O
Canonical SMILESCACTVS3.385 CC(=O)c1oc2C(=O)c3ccccc3C(=O)c2c1
Canonical SMILESOpenEye OEToolkits2.0.7 CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O
InChIInChI1.06 InChI=1S/C14H8O4/c1-7(15)11-6-10-12(16)8-4-2-3-5-9(8)13(17)14(10)18-11/h2-6H,1H3
InChIKeyInChI1.06 DPHUWDIXHNQOSY-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB12155 
NameNapabucasin
Groups investigational
DescriptionNapabucasin has been investigated for the treatment of Colorectal Carcinoma.
SynonymsNapabucasin
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Naphthalenes
  • Quinones
CAS number83280-65-3

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Signal transducer and activator of transcription 3MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKE...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 10331844
ChEMBL CHEMBL64130